Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB vs TOLTERODINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOCILIZUMAB vs TOLTERODINE: Safety Overview

Metric TOCILIZUMAB TOLTERODINE
Total FAERS Reports 98,443 2,422
Deaths Reported 9,543 122
Death Rate 9.7% 5.0%
Hospitalizations 24,039 465
Average Patient Age 52.2 yrs 67.8 yrs
% Female Patients 84.5% 79.5%
FDA Approval Date N/A Aug 11, 2015
Manufacturer CELLTRION USA, Inc. Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription